SINGAPORE - Singapore's first cord blood bank Cordlife Group Limited has officially launched Asia's largest private cord blood storage facility with the inauguration of its new premises at A'Posh Bizhub in Yishun yesterday.
The 23,000 square foot premises has a storage capacity of up to 650,000 cord blood units.
The Group collects, processes, tests and stores stem cells from the umbilical cord blood of a child at birth. Cord blood cells has been shown to play a vital role in the treatment of blood and immune system related genetic diseases, cancers, and blood disorders.
The customers are then allowed to use their child's cord blood stem cells for treatment later in his or her life if their child so requires.
The facility is also the first private facility in Asia to adopt Sepax 2 - a Swiss-made automated stem cell processing system that maximises automation while ensuring consistently high cell recoveries.
"Our first and foremost mandate is to serve parents who seek a life-time protection for their children through the storage of their children's umbilical cord blood units," said Dr Ho Choon Hou, Cordlife's Chairman and Non-Executive Director.
"Our new facility, equipped with state-of-the-art technology, continues to enable us to fulfil our stewardship role of safeguarding the future of our clients and their families."
Since its inception in 2001, Cordlife has released nine cord blood units to its clients for use in the treatment of cerebral palsy, leukaemia and neuroblastoma.